BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai Z, Zhang J, Wu Q, Chen J, Liu J, Wang L, Chen C, Xu J, Zhang H, Shi C, Li Z, Fang H, Lin C, Tang D, Wang D. The role of microbiota in the development of colorectal cancer. Int J Cancer 2019;145:2032-41. [PMID: 30474116 DOI: 10.1002/ijc.32017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 El-sayed NNE, Zaki MEA, Al-hussain SA, Ben Bacha A, Berredjem M, Masand VH, Almarhoon ZM, Omar HS. Synthesis and Evaluation of Some New 4H-Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations. Pharmaceuticals 2022;15:891. [DOI: 10.3390/ph15070891] [Reference Citation Analysis]
2 Lee SHF, Ahmad SR, Lim YC, Zulkipli IN. The Use of Probiotic Therapy in Metabolic and Neurological Diseases. Front Nutr 2022;9:887019. [DOI: 10.3389/fnut.2022.887019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther 2022;7:135. [PMID: 35461318 DOI: 10.1038/s41392-022-00974-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
4 Tonacci A, Scafile A, Billeci L, Sansone F. Electronic Nose and Tongue for Assessing Human Microbiota. Chemosensors 2022;10:85. [DOI: 10.3390/chemosensors10020085] [Reference Citation Analysis]
5 Liu X, Jin G, Tang Q, Huang S, Zhang Y, Sun Y, Liu T, Guo Z, Yang C, Wang B, Jiang K, Zhong W, Cao H. Early life Lactobacillus rhamnosus GG colonisation inhibits intestinal tumour formation. Br J Cancer. [DOI: 10.1038/s41416-021-01562-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xing J, Fang Y, Zhang W, Zhang H, Tang D, Wang D. Bacterial driver-passenger model in biofilms: a new mechanism in the development of colorectal cancer. Clin Transl Oncol 2022;24:784-95. [PMID: 35000132 DOI: 10.1007/s12094-021-02738-y] [Reference Citation Analysis]
7 Liu C, Li Z, Ding J, Zhen H, Fang M, Nie C. Species-Level Analysis of the Human Gut Microbiome Shows Antibiotic Resistance Genes Associated With Colorectal Cancer. Front Microbiol 2021;12:765291. [PMID: 34975790 DOI: 10.3389/fmicb.2021.765291] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Huët MAL, Lee CZ, Rahman S. A review on association of fungi with the development and progression of carcinogenesis in the human body. Curr Res Microb Sci 2022;3:100090. [PMID: 34917994 DOI: 10.1016/j.crmicr.2021.100090] [Reference Citation Analysis]
9 De Silva S, Tennekoon KH, Karunanayake EH. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity. Onco Targets Ther 2021;14:5115-29. [PMID: 34712050 DOI: 10.2147/OTT.S329383] [Reference Citation Analysis]
10 Chen Y, Liu B, Wei Y, Kuang DM. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy. Pharmacol Res 2021;174:105966. [PMID: 34728366 DOI: 10.1016/j.phrs.2021.105966] [Reference Citation Analysis]
11 Cheng P, Shen P, Shan Y, Yang Y, Deng R, Chen W, Lu Y, Wei Z. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy. Front Cell Dev Biol 2021;9:626045. [PMID: 34568308 DOI: 10.3389/fcell.2021.626045] [Reference Citation Analysis]
12 Spyrou N, Vallianou N, Kadillari J, Dalamaga M. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era. Seminars in Cancer Biology 2021;73:356-76. [DOI: 10.1016/j.semcancer.2021.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kaźmierczak-Siedlecka K, Roviello G, Catalano M, Polom K. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers. Nutrients 2021;13:2674. [PMID: 34444834 DOI: 10.3390/nu13082674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Dalal N, Jalandra R, Bayal N, Yadav AK, Harshulika, Sharma M, Makharia GK, Kumar P, Singh R, Solanki PR, Kumar A. Gut microbiota-derived metabolites in CRC progression and causation. J Cancer Res Clin Oncol 2021. [PMID: 34273006 DOI: 10.1007/s00432-021-03729-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Vallianou N, Kounatidis D, Christodoulatos GS, Panagopoulos F, Karampela I, Dalamaga M. Mycobiome and Cancer: What Is the Evidence? Cancers (Basel) 2021;13:3149. [PMID: 34202433 DOI: 10.3390/cancers13133149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Biondi A, Basile F, Vacante M. Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis. World J Gastrointest Oncol 2021; 13(6): 495-508 [PMID: 34163569 DOI: 10.4251/wjgo.v13.i6.495] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Shen J, Li P, Liu S, Liu Q, Li Y, Zhang Z, Yang C, Hu M, Sun Y, He C, Xiao P. The chemopreventive effects of Huangqin-tea against AOM-induced preneoplastic colonic aberrant crypt foci in rats and omics analysis. Food Funct 2020;11:9634-50. [PMID: 33048099 DOI: 10.1039/d0fo01731k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ren L, Ye J, Zhao B, Sun J, Cao P, Yang Y. The Role of Intestinal Microbiota in Colorectal Cancer. Front Pharmacol 2021;12:674807. [PMID: 33959032 DOI: 10.3389/fphar.2021.674807] [Reference Citation Analysis]
19 El-Sayed A, Aleya L, Kamel M. The link among microbiota, epigenetics, and disease development. Environ Sci Pollut Res Int 2021;28:28926-64. [PMID: 33860421 DOI: 10.1007/s11356-021-13862-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mo S, Wang H, Han L, Xiang W, Dai W, Zhao P, Pei F, Su Z, Ma C, Li Q, Wang Z, Cai S, Wang H, Liu R, Cai G. Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis. Front Oncol 2021;11:643136. [PMID: 33718241 DOI: 10.3389/fonc.2021.643136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Fang Y, Yan C, Zhao Q, Xu J, Liu Z, Gao J, Zhu H, Dai Z, Wang D, Tang D. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered 2021;12:720-35. [PMID: 33618627 DOI: 10.1080/21655979.2021.1889109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
22 Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R, Sharma J, Karmakar S. Exploring the Role of Gut Microbiome in Colon Cancer. Appl Biochem Biotechnol 2021;193:1780-99. [PMID: 33492552 DOI: 10.1007/s12010-021-03498-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
23 Luck ME, Herrnreiter CJ, Choudhry MA. Gut Microbial Changes and their Contribution to Post-Burn Pathology. Shock 2021;56:329-44. [PMID: 33481548 DOI: 10.1097/SHK.0000000000001736] [Reference Citation Analysis]
24 Chen YC, Miao ZF, Yip KL, Cheng YA, Liu CJ, Li LH, Lin CY, Wang JW, Wu DC, Cheng TL, Wang JY. Gut Fecal Microbiota Transplant in a Mouse Model of Orthotopic Rectal Cancer. Front Oncol 2020;10:568012. [PMID: 33194651 DOI: 10.3389/fonc.2020.568012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Al Theyab A, Almutairi T, Al-Suwaidi AM, Bendriss G, McVeigh C, Chaari A. Epigenetic Effects of Gut Metabolites: Exploring the Path of Dietary Prevention of Type 1 Diabetes. Front Nutr 2020;7:563605. [PMID: 33072796 DOI: 10.3389/fnut.2020.563605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
26 Dai Z, Zhang J, Wu Q, Fang H, Shi C, Li Z, Lin C, Tang D, Wang D. Intestinal microbiota: a new force in cancer immunotherapy. Cell Commun Signal 2020;18:90. [PMID: 32522267 DOI: 10.1186/s12964-020-00599-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 14.5] [Reference Citation Analysis]
27 Kaźmierczak-Siedlecka K, Daca A, Fic M, van de Wetering T, Folwarski M, Makarewicz W. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes 2020;11:1518-30. [PMID: 32453670 DOI: 10.1080/19490976.2020.1764309] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 19.5] [Reference Citation Analysis]
28 Kaźmierczak-Siedlecka K, Dvořák A, Folwarski M, Daca A, Przewłócka K, Makarewicz W. Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis. Cancers (Basel) 2020;12:E1326. [PMID: 32455985 DOI: 10.3390/cancers12051326] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
29 Han S, Wu W, Da M, Xu J, Zhuang J, Zhang L, Zhang X, Yang X. Adequate Lymph Node Assessments and Investigation of Gut Microorganisms and Microbial Metabolites in Colorectal Cancer. Onco Targets Ther 2020;13:1893-906. [PMID: 32184624 DOI: 10.2147/OTT.S242017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Huang CC, Shen MH, Chen SK, Yang SH, Liu CY, Guo JW, Chang KW, Huang CJ. Gut butyrate-producing organisms correlate to Placenta Specific 8 protein: Importance to colorectal cancer progression. J Adv Res 2020;22:7-20. [PMID: 31956438 DOI: 10.1016/j.jare.2019.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer.Gastroenterology. 2020;158:322-340. [PMID: 31586566 DOI: 10.1053/j.gastro.2019.06.048] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 30.7] [Reference Citation Analysis]
32 Saus E, Iraola-Guzmán S, Willis JR, Brunet-Vega A, Gabaldón T. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol Aspects Med 2019;69:93-106. [PMID: 31082399 DOI: 10.1016/j.mam.2019.05.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 22.3] [Reference Citation Analysis]
33 Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N. Obesity, Inflammation, and Prostate Cancer. J Clin Med 2019;8:E201. [PMID: 30736371 DOI: 10.3390/jcm8020201] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]